Screening Tests

Hemostasis Reagents

Screening tests allow the detection of coagulation abnormalities

Hemostasis screening tests,Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT), are frequently used to assess the bleeding risk, for example before an operation or an invasive procedure. These tests can detect coagulation abnormalities (with the exception of factor XIII deficiency) but are not suitable for primary hemostasis disorders. 

HORIBA Medical offers a new range of liquid, ready-to-use reagents for more accurate global screening tests:
•    Yumizen G PT Liq
•    Yumizen G APTT Liq 4

The Thrombin Time is a screening test to assess abnormalities of fibrinogen and to detect inhibitors against thrombin or fibrin.
•    Yumizen G TT, a human thrombin for perfect assessment of fibrin formation.

*This product may not be available in your country or region at this time. Please contact your HORIBA Medical sales representative or distributor for more information.